A comprehensive review of COVID-19 in India: A frequent catch of the information
- PMID: 33438250
- PMCID: PMC8014063
- DOI: 10.1002/bab.2101
A comprehensive review of COVID-19 in India: A frequent catch of the information
Abstract
The arrival of novel health crisis by a novel member of coronavirus group named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by World Health Organization took the whole world in global emergency by affecting 206 countries. The virus infects 206 countries with 86,839,226 confirmed cases, 61,565,949 recoveries, and 1,876,243 deaths as on January 6, 2021. Evidence pointed out the fact that virus might first originated in bats in China and it took only 2 months to spread over almost every country of the world. SARS-CoV-2 belongs to beta coronavirus and is enveloped, positive sense, and single-stranded RNA virus. The treatment would be difficult as SARS-CoV-2 is an RNA virus and thus the mutation rate is higher in comparison with the DNA viruses. The virus infection also leads to generation of effective protective immune response of tumor necrosis factor, interleukin (IL)-1β, IL-6, IL-8, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and so on that may help in virus elimination. The speed of the global spread of the current pandemic is of major concern and it has created a significant threat to economic and human health across the world. In India, the infection spreads with an infection and fatality rates of the disease are 1.7% and 2.8%, respectively. By this review, we want to emphasize the actual situation and major factors associated with COVID-19 pandemic, its significance, destructions, important findings, treatments, and preventive measures taken by all nations to provide better cure without having much loss.
Keywords: COVID-19; India; SARS-CoV-2; coronavirus; pandemic.
© 2021 International Union of Biochemistry and Molecular Biology, Inc.
Figures


Similar articles
-
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4. J Infect Public Health. 2020. PMID: 32778421 Free PMC article.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.Front Immunol. 2020 Aug 19;11:1880. doi: 10.3389/fimmu.2020.01880. eCollection 2020. Front Immunol. 2020. PMID: 32973779 Free PMC article. Review.
-
A Review of Potential Therapeutic Strategies for COVID-19.Viruses. 2022 Oct 25;14(11):2346. doi: 10.3390/v14112346. Viruses. 2022. PMID: 36366444 Free PMC article. Review.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Comparative performance of two automated machine learning platforms for COVID-19 detection by MALDI-TOF-MS.PLoS One. 2022 Jul 29;17(7):e0263954. doi: 10.1371/journal.pone.0263954. eCollection 2022. PLoS One. 2022. PMID: 35905092 Free PMC article.
-
Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine.Vaccines (Basel). 2022 Oct 10;10(10):1689. doi: 10.3390/vaccines10101689. Vaccines (Basel). 2022. PMID: 36298554 Free PMC article. Review.
-
COVID-19: Insights into Potential Vaccines.Microorganisms. 2021 Mar 15;9(3):605. doi: 10.3390/microorganisms9030605. Microorganisms. 2021. PMID: 33804162 Free PMC article. Review.
-
Navigating the Pandemic: An Exploration of Medical Practitioners' Preparedness, Concerns, Adaptations, and Practices During the COVID-19 Epidemic in India.Cureus. 2023 Nov 12;15(11):e48677. doi: 10.7759/cureus.48677. eCollection 2023 Nov. Cureus. 2023. PMID: 38090450 Free PMC article.
References
-
- Bogoch, A. , Watts, A. , Thomas‐Bachli, C. , Bogoch, I. I., Watts, A., Thomas‐Bachli, A., Huber, C., Kraemer, M., and Khan, K. (2020) Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J. Trav. Med. 13, taaa008. https://pubmed.ncbi.nlm.nih.gov/31943059/. - PMC - PubMed
-
- Lu, H. , Stratton, C. W. , Tang, Y. W. , Lu, H., Stratton, C. W., and Tang, Y. W. (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol. 92, 401–402. https://pubmed.ncbi.nlm.nih.gov/31950516/. - PMC - PubMed
-
- Zhao, S. , Lin, Q. , Ran, J. , Zhao, S., Lin, Q., Ran, J., Musa, S. S., Yang, G., Wang, W., Lou, Y., Gao, D., Yang, L., He, D., and Wang, M. H. (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019‐nCoV) in China, from 2019 to 2020: A data‐driven analysis in the early phase of the outbreak. Int. J. Infect. 92, 214–217. https://pubmed.ncbi.nlm.nih.gov/32007643/. - PMC - PubMed
-
- Hussain, S. , Pan, J. , Chen, Y. , Hussain, S., Pan, J., Chen, Y., Yang, Y., Xu, J., Peng, Y., Wu, Y., Li, Z., Zhu, Y., Tien, P., and Guo, D. , (2005) Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J. Virol. 79(9), 5288–5295. https://pubmed.ncbi.nlm.nih.gov/15827143/. - PMC - PubMed
-
- Wang, L. F. , Shi, Z. , Zhang, S. , Wang, L. F., Shi, Z., Zhang, S., Field, H., Daszak, P., and Eaton, B. T. (2006) Review of bats and SARS. Emerg. Infect. Dis. 12(12), 1834–1840. https://pubmed.ncbi.nlm.nih.gov/17326933/. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous